| Industry | Medical Instruments & Supplies |
| Sector | Health Care |
| Main Index | MIB40 |
| Company's (investor relations) website | Company Website |
| Next earnings report | NaT |
| Reporting currency | EUR |
| Fiscal year period | 01/01-31/12 |
| Reporting cycle | Quarter |
| Last processed report | Q4-2021 |
| Market Capitalization (in million) | € 6,338 |
| Enterprise value | € 7,175 |
| Shares outstanding (in million) | 224.2 |
| ROE (Return on Equity) | 0.0% |
| ROA (Return on Assets) | 3.1% |
| EPS (Earnings Per Share) | € 0.70 |
| PE (Price/Earnings) | 30.0 |
| Beta | 0.43 |
| Implicit value range | 0.8357058394188979|
| Investment advice | Buy |
| Trading advice (based on moving averages) | Sell |
| Latest StockAdvisor Algorithmic advice see Return on Advice Graph | Buy |
| Fundamental Strength (scale 0 - 100) | 69 |
| Trading Strength (scale 0 - 100) | 45 |
| 1 year performance | 2.21% |
| 52 Weeks range | € 25.27 - 36.01 |
| 10 Day's Moving Average | Downtrend |
| 50 Day's Moving Average | Downtrend |
| 200 Day's Moving Average | Uptrend |
| Revenue (last year in million) | € 1,987 |
| 5 year Revenue growth (5 year CAGR) | 8.5% |
| Net income (last year in million) | € 158 |
| 5 year Net income growth (5 year CAGR) | 16.3% |
| 1 year target | € 72.52 |
| 3 year target | € 81.25 |
| Amplifon SpA is a company based in Italty. Amplifon provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. Amplifon operates in three segments based on geography: Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. Amplifon operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear. The majority of Amplifon's direct points of sale are in Italy. |
| Amplifon SpA |
| Carl Zeiss Meditec AG |
| Essilor International SA |
| Gerresheimer AG |
| Getinge AB |
| Intuitive Surgical Inc. |
| Sartorius Aktiengesellschaft |
| Description | 2020 | 2021 | 2022 | 2023 * | 2024 * | 2025 * |
| Revenue | € 1,555 | € 1,987 | € 2,373 | € 2,646 | € 2,853 | € 3,017 |
| Net income | € 100 | € 158 | € 210 | € 242 | € 264 | € 282 |
| EPS | € 0.45 | € 0.70 | € 0.94 | € 1.08 | € 1.18 | € 1.12 |
| PE | 75.23 | 67.56 | 62.43 | 61.64 | 61.54 | 68.78 |
| Prices eoy | € 34.04 | € 47.45 | € 58.39 | € 66.45 | € 72.52 | € 77.33 |
| Dividend | € 0.16 | € 0.19 | € 0.22 | € 0.25 | € 0.28 | € 0.30 |
| Div-% | 0.5% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% |
| Description | Q1-22 | Q2-22 | Q3-22 | Q4-22 | Q1-23 | Q2-23 | Q3-23 | Q4-23 |
| Revenue | € 572 | € 595 | € 587 | € 618 | € 640 | € 658 | € 670 | € 678 |
| Net income | € 50 | € 55 | € 49 | € 56 | € 58 | € 61 | € 61 | € 61 |
| EPS | € 0.22 | € 0.24 | € 0.22 | € 0.25 | € 0.26 | € 0.27 | € 0.27 | € 0.27 |
| PE | 60.26 | 60.44 | 61.48 | 62.43 | 61.15 | 61.38 | 61.61 | 61.64 |
| Prices eoq | € 40.54 | € 29.25 | € 26.90 | € 58.39 | € 59.43 | € 61.29 | € 64.81 | € 66.45 |
| NORM | ||||
| Description | Actuals | Progressive | Neutral | Conservative |
| Solvency | 24.9% | < 25% | 25-35% | > 35% |
| ROE (return on equity) | 12.5% | > 12% | 10-12% | < 10% |
| ROA (return on assets) | 3.1% | > 5% | 5% | < 5% |
| Current ratio | 1.3 | < 1 | 1-1.5 | > 1.5 |
| Turnover rate | 2.1 | < 1 | 1-1.5 | > 1.5 |
| WACC | 7.04% | > 10% | 10% | < 10% |
| Beta | 0.43 | > 1 | 1 | < 1 |